comparemela.com

Latest Breaking News On - Marianne de backer - Page 3 : comparemela.com

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Vir, in midst of restructuring, loses its chief medical officer

Vir Biotechnology Announces Dr Phil Pang Will Step Down as Chief Medical Officer

Vir Biotechnology, Inc. today announced that Executive Vice President, and Chief Medical Officer, Phil Pang, M.D., Ph.D., has decided to leave the company at the end of March 2024 to spend more time.

Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Are

– Reinforcing strategic focus on chronic hepatitis delta and chronic hepatitis B clinical programs and antibody platform to target infectious diseases, autoimmune diseases, and oncology –– Reducing workforce by approximately 12% and consolidating geographic footprint –– Anticipate annual savings of at least $40 mill.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.